FDA批准数字疗法产品作为老年性痴呆突破性疗法地位

2021-08-14 MedSci原创 MedSci原创

FDA 授予 Dthera Sciences 开发阶段产品 DTHR-ALZ 突破性设备称号,该产品旨在减轻与阿尔茨海默病相关的躁动和抑郁。 如果获得批准,DTHR-ALZ 将成为该适应症的第一种非药

FDA 授予 Dthera Sciences 开发阶段产品 DTHR-ALZ 突破性设备称号,该产品旨在减轻与阿尔茨海默病相关的躁动和抑郁。 如果获得批准,DTHR-ALZ 将成为该适应症的第一种非药物处方治疗。DTHR-ALZ通过一种名为 回忆治疗(Reminiscence Therapy)的既定方法来抑制阿尔茨海默病患者的躁动和抑郁。 它使用定制的平板电脑通过自动聊天机器人重播令人难忘的照片和语音剪辑(从家庭成员那里收集)。 DTHR-ALZ 是一种处于开发阶段的处方数字疗法,它以数字方式提供回忆疗法,通过人工智能使用患者的生物反馈自动优化疗法。 Dthera Sciences 负责科学和监管事务的副总裁 Martin Culjat 博士在一份声明中表示:“这一突破性的指定为我们提供了一个绝佳的机会来加快我们的数字治疗设备的开发。我们深感荣幸。 FDA 已确认 DTHR-ALZ 符合此指定的要求,我们渴望在整个过程中与 FDA 合作。” 该疗法通过带有前置摄像头的定制平板电脑提供,并显示亲人照片或患者家人上传的回忆等内容。该设备使用人工智能根据患者的多种生物反馈形式自动优化治疗,调

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1839934, encodeId=80bc1839934f0, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Fri Jun 17 01:12:59 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536219, encodeId=d16b153621989, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75538, encryptionId=75fbe553800, topicName=突破性疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eca12667393, createdName=zhwj, createdTime=Mon Aug 16 11:12:59 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048857, encodeId=b6e8104885e52, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Aug 14 23:12:59 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2022-06-17 bugit
  2. [GetPortalCommentsPageByObjectIdResponse(id=1839934, encodeId=80bc1839934f0, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Fri Jun 17 01:12:59 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536219, encodeId=d16b153621989, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75538, encryptionId=75fbe553800, topicName=突破性疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eca12667393, createdName=zhwj, createdTime=Mon Aug 16 11:12:59 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048857, encodeId=b6e8104885e52, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Aug 14 23:12:59 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1839934, encodeId=80bc1839934f0, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Fri Jun 17 01:12:59 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536219, encodeId=d16b153621989, content=<a href='/topic/show?id=75fbe553800' target=_blank style='color:#2F92EE;'>#突破性疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75538, encryptionId=75fbe553800, topicName=突破性疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eca12667393, createdName=zhwj, createdTime=Mon Aug 16 11:12:59 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048857, encodeId=b6e8104885e52, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Aug 14 23:12:59 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-08-14 junJUN

    老年人痴呆何药可用??

    0

相关资讯

Alzheimer Dementia:牙周炎,或提示痴呆可能性

牙周炎,或提示痴呆可能性

JNNP-额叶痴呆患者,大脑中tau蛋白不均匀分布

-额叶痴呆患者,大脑中tau蛋白不均匀分布

Alzheimer Dementia-注意:痴呆确诊后,次年自杀率大大增加

注意-痴呆确诊后,次年自杀率大大增加

Alzheimers Dementia:白质高信号病变分布特点不同,预测认知能力的效果也不同

WMH是导致AD患者认知能力下降的主要原因,与淀粉样蛋白沉积和萎缩无关

Alzheimer Dementia:长期睡眠不好,容易变“傻”

长期睡眠不好,容易变“傻”